Neuroleptic associated extrapyramidal symptoms.
Maurer
I
I
Zierz
S
S
Möller
H J
HJ
Jerusalem
F
F
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D001921:Brain / Q000187:drug effects; D004249:DNA Damage; D004272:DNA, Mitochondrial / Q000187:drug effects; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis; D004579:Electron Transport / Q000187:drug effects; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D014150:Antipsychotic Agents; D004272:DNA, Mitochondrial